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Assisted reproductive technology (ART†) has been recognized for its success in treating
infertility, a condition that affects 15 percent of couples in the united States. The most pop-
ular option is in vitro fertilization (IVF), which relies on embryo culture, selection, and trans-
fer for implantation, with the ultimate aim of pregnancy. Previous embryo selection methods
relied on morphological factors to select for greatest viability. At Yale’s Frontiers in Repro-
duction Conference on April 29, 2011, at the New Haven Lawn Club, Dr. Denny Sakkas of
Yale’s Department of Obstetrics, Gynecology, and Reproductive Sciences presented a par-
adigm shift: using morphological factors along with metabolic, protein, and genetic markers
in culture media to enhance embryo selection and IVF success rates. 
Infertility affects more than 6.1 million
couples in the United States [1,2]. Infertil-
ity refers to either the inability to conceive
after a year of unprotected intercourse or
the inability to carry a pregnancy to term.
The countless contributing factors are con-
tingent on the fertility of both the male and
female and include genetics, lifestyle, en-
vironmental toxins, tubal blockage, low
semen quantity and quality, and age. Al-
though drugs exist for the management and
treatment of reproductive disorders such as
oligospermia in males and endometriosis in
females, they prove to be marginally help-
ful at best [3]. 
As a result, many couples turn to as-
sisted reproductive technology (ART) and,
in particular, in vitro fertilization (IVF), a
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assists in the birth of more than 38,000 ba-
bies worldwide each year [4]. The future of
fertility and IVF were underscored at Yale’s
Frontiers in Reproduction Conference on
April 29, 2011, at the New Haven Lawn
Club. Expanding upon the current methods
of embryo culture, selection, and transfer,
Dr. Denny Sakkas of Yale’s Department of
Obstetrics, Gynecology, and Reproductive
Sciences presented on “The IVF Laboratory
of the Future” and groundbreaking develop-
ments furthering the field of reproductive
fertility. 
In 1978, Robert Edwards and Patrick
Steptoe published “Birth After the Reim-
plantation  of  a  Human  Embryo”  in  The
Lancet [5]. This was the first case of a suc-
cessful birth through IVF, and 30 years later,
3 million babies have been born through the
same technique. The method is a multi-step
process consisting of ovarian hyperstimula-
tion, oocyte retrieval, fertilization, embryo
culture, embryo selection, and embryo trans-
fer. The lack of current treatments to in-
crease the quality of the sperm or egg is
compensated for by using increased num-
bers:  Multiple  follicles  and  eggs  in  the
woman are induced to mature and ovulate
per menstrual cycle [6]. One criticism of
IVF is the increased rates of multiple preg-
nancies, which heightens risks of premature
delivery and low birth weights and endan-
gers both the mother and children. Restric-
tions  in  some  countries  on  the  embryo
number transferred have reduced multiple
pregnancy dangers [7]. At the conference,
Dr. Sakkas discussed current and prospec-
tive methods in improving embryo selection
to optimize pregnancy and minimize the risk
of multiple births. 
Currently, embryo selection is based on
embryo morphology and the rate of embryo
development in culture. Positive selection
criteria include the number of blastomeres,
the absence of multinucleation, early cleav-
age to the two-cell stage, and a low percent-
age of cell fragments in embryos [8]. Further
factors found to increase pregnancy and im-
plantation rates include the bastocoelic cav-
ity expansion state and the cohesiveness and
number of the inner cell mass and trophec-
todermal cells [9]. A sequential embryo as-
sessment  model  along  with  a  computer
algorithm is currently used to take these fac-
tors into account and has been able to select
for embryo development into blastocysts in
86 percent of cases [10].  
Despite the stringent and vigilant mor-
phological criteria, per transfer of 2.3 em-
bryos, only 52.3 percent result in live birth.
Of these ART pregnancies, more than 30
percent are multiple-infant births [11]. The
increased incidence of preterm delivery in
these multiple pregnancies has drastic con-
sequences on public health, as preterm in-
fants require longer stays in the neonatal
intensive care unit and are more vulnerable
to respiratory, gastrointestinal, central nerv-
ous,  and  immune  system  complications.
These infants can also sustain longer-term
problems, including cerebral palsy, mental
retardation, and learning difficulties. Thus,
it becomes imperative to develop embryo
grading and evaluation systems to select for
the greatest viability. Current developments
beyond morphological criteria have looked
into metabolic parameters of embryos in cul-
ture media. These metabolic markers in-
clude decreased pyruvate [12] and increased
glucose uptake [13] by the embryos, as well
as  elevated  asparagine  and  decreased
glycine and leucine levels [14] in the culture
media.  
Dr. Sakkas reported that in 2008, the
Department of Obstetrics, Gynecology, and
Reproductive Sciences at Yale, in conjunc-
tion with the Department of Chemistry at
McGill  University,  investigated  the
metabolomic profiling of embryo culture
media through proton nuclear magnetic res-
onance (1H NMR). They discovered that the
metabolomics profile correlated with em-
bryo reproductive potential. From the pro-
ton NMR spectrum, alanine, pyruvate, and
glucose levels were reduced in the culture
media  of  embryos  that  resulted  in  preg-
nancy. Glutamate levels were found to be
higher compared to embryos that failed to
implant, possibly due to its generation from
ʱ-ketoglutarate  and  ammonium,  thereby
lowering the potentially toxic ammonium to
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ability to identify true implantations/preg-
nancies ― of 88.2 percent and a specificity
― the ability to correctly predict no im-
plantations/pregnancies ― of 88.2 percent
was achieved through 1H NMR [15]. 
Further reproductive potential can be fa-
cilitated by the examination of protein mark-
ers in the embryo culture media. In one study
by Noci et al., soluble human leukocyte anti-
gen-G (sHLA-G) was isolated and consid-
ered as a possible protein marker of embryo
reproductive  potential.  The  presence  of
sHLA-G shows no correlation with embryo
morphology, and the lack of sHLA-G in cul-
ture media has a negative predictive value
[16]. In another study in which sHLA-G-
positive embryos were transferred, implan-
tation and pregnancy rates were 44 percent
and 75 percent, respectively, compared to 14
percent and 23 percent of transferred sHLA-
G-negative  embryos  [17]. A  protein  bio-
marker that has been found to be upregulated
and increased during embryo maturation into
the blastocyst stage is a Day 5 secretome ―
a set of proteins secreted from the cell ― re-
sembling ubiquitin. Ubiquitin has been im-
plicated  in  the  turnover  of  key  signaling
molecules during implantation [18]. 
Genomic markers are at the research
forefront of improving embryo selection and
IVF success. The cumulus cells (CCs) that
surround the oocyte from fertilization until
implantation have been analyzed and gene-
profiled to gauge embryo potential: the like-
lihood of an embryo to implant and lead to
a successful pregnancy. Several genes ex-
pressed in CCs have been correlated with
predicting pregnancy, including cyclooxy-
genase  2  (COX2)  [19,20],  steroidogenic
acute regulatory protein (STAR), and pen-
traxin 3 (PTX3) [21]. Two upregulated bio-
markers have been identified in the CCs of
successful  pregnancies,  BCL2L11  and
PCK1, which are involved in apoptosis of
abnormal cells and gluconeogenesis [22].
Implications of these findings can lead to fu-
ture IVF techniques of CC collection post
oocyte retrieval, followed by gene profiling
of embryos to recognize which need fresh
placement and which are most viable. 
Pioneering developments in the field of
ART have expanded the embryo selection
process beyond measures of morphology.
Although current methods in selection have
offered some success, recent noninvasive as-
sessment of embryo potential will allow for
more proficient selection of the most viable
embryos. From Dr. Sakkas’ discussion, the
selection process that was once a “beauty
contest,” simply evaluating embryo appear-
ance, will soon include metabolic, protein,
and genomic markers as assessment criteria. 
Machines  employing  metabolomics
culture assessment have been available since
the start of 2011 in Europe and India through
the  Massachusetts-based  firm  Molecular
Biometrics. The company is aiming for its
“ViaMetrics-E” system to acquire Food and
Drug Administration (FDA) approval and
begin United States sales by the fourth quar-
ter of 2011. This metabolomics machine is
expected to improve IVF success rates, re-
duce costs, and diminish dangers associated
with multiple pregnancies and preterm de-
liveries. These combined components pro-
vide an improved understanding of embryo
viability, allowing for the identification of
embryos that are most likely to result in a
pregnancy. Ultimately, the amalgamation of
all factors will provide greater success to the
field of IVF toward achieving the goal of
one healthy baby per pregnancy. 
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